NEURO2022

Presentation information

Print

Symposia

[4S05a] Update of oligonucleotide therapy as a major trend of drug discovery for intractable neurological diseases

Sun. Jul 3, 2022 2:00 PM - 4:00 PM Room 5 (Conference Building B2 (Okinawa Convention Center))

Chair: Takanori Yokota

[4S05a-01] Current Status of ASO Therapy for ALS

*John Ravits1 (1. University of California, San Diego)

Keywords:SOD1, C9ORF72, FUS, ATXN2

Abstract password authentication.
A password is required to view the full text of the abstract. Please enter the following password.

PW: Neuro2022

Password